Hematology/Oncology News

The FDA approved amivantamab-vmjw plus lazertinib as first-line treatment for certain adults with non-small cell lung cancer.

A platelet reactivity score that identifies people with a hyperreactive platelet phenotype can be used to determine those who might be at elevated risk for a cardiovascular event, researchers reported in Nature Communications.

Twelve months after indwelling pleural catheter insertion vs. chemical pleurodesis for malignant pleural effusions, the average cost of health care was lower, according to results published in Annals of the American Thoracic Society.

Six months after the ransomware attack on Change Healthcare, the far-reaching impacts on medical practices, providers and patients continue to be felt.

In his keynote address at this year’s Ending Clinician Burnout Global Summit, Thom Mayer, MD, FACEP, likened the health care practitioners in the audience to the professional football players he routinely treats.

Low levels of alcohol consumption may be associated with increased mortality risk in adults with health-related or socioeconomic risk factors, results from a recent analysis suggested.

Cognition appeared associated with likelihood that individuals would return to work 2 years after breast cancer diagnosis, according to results of a case series study.

The addition of tafasitamab-cxix to lenalidomide and rituximab improved outcomes for patients with relapsed or refractory follicular lymphoma, according to the agent’s manufacturer.

Among older women, messaging strategies significantly increased support for and intentions of breast cancer screening cessation, with the strongest effects occurring when messages were delivered over time from multiple sources, data show.

As medical technology quickly evolves, practices in nearly all areas of medicine must frequently evaluate equipment upgrades and new purchases of new technology to stay at the forefront of patient care.